Financing for tuberculosis prevention, diagnosis and treatment services in the Western Pacific Region in 2005–2020

Authors

  • Fukushi Morishita End TB and Leprosy Unit, World Health Organization Regional Office for the Western Pacific, Manila, Philippines
  • Hend Elsayed End TB and Leprosy Unit, World Health Organization Regional Office for the Western Pacific, Manila, Philippines
  • Tauhid Islam End TB and Leprosy Unit, World Health Organization Regional Office for the Western Pacific, Manila, Philippines
  • Kalpeshsinh Rahevar End TB and Leprosy Unit, World Health Organization Regional Office for the Western Pacific, Manila, Philippines
  • Kyung Hyun Oh End TB and Leprosy Unit, World Health Organization Regional Office for the Western Pacific, Manila, Philippines
  • Manami Yanagawa End TB and Leprosy Unit, World Health Organization Regional Office for the Western Pacific, Manila, Philippines
  • Katherine Floyd Global TB Programme, World Health Organization, Geneva, Switzerland
  • Inés Garcia Baena Global TB Programme, World Health Organization, Geneva, Switzerland

DOI:

https://doi.org/10.5365/wpsar.2023.14.3.976

Keywords:

tuberculosis, health financing, preventive medicine, diagnosis, treatment, Asia

Abstract

Objective: This paper provides an overview of financing for tuberculosis (TB) prevention, diagnostic and treatment services in the World Health Organization (WHO) Western Pacific Region during 2005–2020.

Methods: This analysis uses the WHO global TB finance database to describe TB funding during 2005–2020 in 18 low- and middle-income countries (LMICs) in the Western Pacific Region, with additional country-level data and analysis for seven priority countries: Cambodia, China, the Lao People’s Democratic Republic, Mongolia, Papua New Guinea, the Philippines and Viet Nam.

Results: Funding for the provision of TB prevention, diagnostic and treatment services in the 18 LMICs tripled from
US$ 358 million in 2005 to US$ 1061 million in 2020, driven largely by increases in domestic funding, which rose from US$ 325 million to US$ 939 million over the same period. In the seven priority countries, TB investments also tripled, from US$ 340 million in 2005 to US$ 1020 million in 2020. China alone accounted for much of this growth, increasing its financing for TB programmes and services five-fold, from US$ 160 million to US$ 784 million. The latest country forecasts estimate that US$ 3.8 billion will be required to fight TB in the seven priority countries by 2025, which means that unless additional funding is mobilized, the funding gap will increase from US$ 326 million in 2020 to US$ 830 million by 2025.

Discussion: Increases in domestic funding over the past 15 years reflect a firm political commitment to ending TB. However, current funding levels do not meet the required needs to finance the national TB strategic plans in the priority countries. An urgent step-up of public financing efforts is required to reduce the burden of TB in the Western Pacific Region.

Downloads

Published

18-08-2023

How to Cite

1.
Morishita F, Elsayed H, Islam T, Rahevar K, Oh KH, Yanagawa M, Floyd K, Garcia Baena I. Financing for tuberculosis prevention, diagnosis and treatment services in the Western Pacific Region in 2005–2020. Western Pac Surveill Response J [Internet]. 2023 Aug. 18 [cited 2024 Jul. 16];14(3):13. Available from: https://ojs.wpro.who.int/ojs/index.php/wpsar/article/view/976

Issue

Section

Regional Analysis

Most read articles by the same author(s)

1 2 > >>